Core Viewpoint - Four Seasons Pharmaceutical has been actively repurchasing its shares, indicating a strategy to enhance shareholder value amidst market fluctuations [2] Summary by Category Share Buyback Activity - On October 15, Four Seasons Pharmaceutical repurchased 10 million shares at prices ranging from 1.500 to 1.540 HKD, totaling 15.189 million HKD [2] - The stock closed at 1.530 HKD on the same day, reflecting a decline of 1.92%, with a total trading volume of 205 million HKD [2] - Year-to-date, the company has conducted 14 buybacks, acquiring a total of 141 million shares for an aggregate amount of 122 million HKD [2] Buyback Details - The buyback details are as follows: - October 15: 1,000,000 shares at a maximum price of 1.540 HKD and a minimum of 1.500 HKD, totaling 15.189 million HKD - September 26: 150,000 shares at 1.480 HKD, totaling 2.22 million HKD - September 2: 1,309,600 shares at 1.510 HKD, totaling 19.572 million HKD - June 17: 2,000,000 shares at 1.100 HKD, totaling 21.82 million HKD - May 12: 1,000,000 shares at 0.700 HKD, totaling 0.689 million HKD - May 6: 2,000,000 shares at 0.740 HKD, totaling 1.468 million HKD - May 2: 268,200 shares at 0.710 HKD, totaling 0.190 million HKD - April 30: 68,500 shares at 0.710 HKD, totaling 0.049 million HKD - April 29: 187,400 shares at 0.690 HKD, totaling 0.129 million HKD - April 28: 1,617,400 shares at 0.680 HKD, totaling 1.089 million HKD - April 16: 1,000,000 shares at 0.640 HKD, totaling 0.627 million HKD - April 9: 1,000,000 shares at 0.600 HKD, totaling 0.587 million HKD - April 7: 1,500,000 shares at 0.600 HKD, totaling 0.875 million HKD - February 11: 1,000,000 shares at 0.580 HKD, totaling 0.572 million HKD [2]
四环医药(00460.HK)10月15日回购1000.00万股，耗资1518.90万港元